CIGB-300 (P15-Tat)
Anti-CK2 cyclic cell-penetrating research peptide.
Oncology Research Peptides
RGD (Arg-Gly-Asp) is the minimal three-amino-acid recognition sequence for a subset of integrin receptors, notably αvβ3 and αvβ5. It is studied as a research-grade targeting ligand for integrin-specific nanomedicine construction, PET/SPECT radiotracer and molecular-imaging development, anti-angiogenic and tumor-microenvironment research, and tissue-engineering / cell-adhesion studies on biomaterial scaffolds.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Anti-CK2 cyclic cell-penetrating research peptide.
Telomerase-derived 16-mer research peptide.
PSP-94-derived antitumor research peptide.